500mcg

Tesofensine is a pharmaceutical compound initially developed for neurodegenerative diseases like Parkinson’s. It was found to suppress appetite and promote weight loss. As a serotonin-noradrenaline-dopamine reuptake inhibitor (SNDRI), Tesofensine enhances neurotransmitter activity, offering potential in obesity management. Clinical studies show that a 500 mcg dose effectively reduces body weight in obese patients, but careful monitoring is needed due to possible side effects like increased heart rate.